Home › Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs
 

Keywords :   


Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs

2016-01-12 23:12:49| Biotech - Topix.net

The heads of drugmakers Pfizer and Allergan said Tuesday that the record $160 billion combination they're planning is meant to produce more medicines and boost revenue, not to just slash jobs and other costs as the companies previously have done. The deal announced last November would move Pfizer's official headquarters for tax purposes from New York to Allergan's base in Ireland.

Tags: sales costs produce focused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
15.05Voesh Unveils Body Refining Roller Crme Ahead of Summer 2024
15.05KANSAI HELIOS Completes Acquisition of WEILBURGER Coatings
More »